Denise W. Metry, MD
- Texas Medical Center
Associate Professor of Dermatology and Pediatrics
Baylor College of Medicine
|University of Texas Medical School at Houston||fellowship||Pediatric Dermatology||2000|
|University of Texas Medical School at Houston||residency||Dermatology||1999|
|St. Joseph Hospital Program||internship||Transitional||1996|
|University of Texas Medical School at Houston||medical school||Doctor of Medicine||1995|
Dr. Metry has a special interest in the diagnosis and treatment of children with vascular birthmarks, particularly infantile hemangiomas and PHACE syndrome. She is a founding member of the Hemangioma Investigator Group, an international physician working group established in 2000 to promote hemangioma research and education. She is the author of over 100 manuscripts and book chapters dedicated to furthering our understanding of vascular birthmarks. She has also lectured extensively both nationally and internationally. She hosted the first PHACE research and family meeting at Texas Children's in 2008, from which diagnostic criteria for the syndrome were established. Recently she has extended her passion to international mission work, having traveled to underserved parts of Asia and Africa to provide hemangioma education. Dr. Metry has longstanding expertise in both medical and laser care for vascular birthmarks, including propranolol for hemangiomas, and is dedicated to providing compassionate care for her patients and their families.
|Hemangioma Investigator Group (HIG)||Founding Member|
|International Society for the Study of Vascular Anomalies (ISSVA)||Member|
|National Organization for Vascular Anomalies (NOVA) & Vascular Birthmark Foundation (VBF)||Physician-Patient Liason for PHACE Syndrome|
|Pediatric Dermatology Journal||Editorial Board Member|
|Society of Pediatric Dermatology (SPD)||Executive Board Member and Vice?Chair, Communications|
Metry D, Frieden IJ, Hess C, et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatric Dermatology 2013 Jan-Feb;30(1):71-89.